Introduction {#S1}
============

Innate lymphoid cells (ILCs) represent a family of lymphocytes that differ from B and T cells since they lack recombination activating gene (RAG)-dependent rearranged antigen receptors. ILCs share the dependence on Id2 transcriptional repressor and on the common γ chain cytokine receptor for their development. ILCs have been classified into three main groups according to their transcription factor and cytokine profile. Group 1 ILCs express the T-box transcription factor T-bet (*Tbx21*) and mainly express IFNγ and TNF. Group 2 ILCs (ILC2) depend on GATA binding protein-3 transcription factor and produce type-2 cytokines. Finally, group 3 ILCs (ILC3) express the retinoic acid receptor (RAR)-related orphan receptor (ROR)γt, and produce IL-17 and IL-22 ([@B1], [@B2]).

Group 1 ILCs include "helper-ILC1" (hereinafter referred to as ILC1) and "cytotoxic-ILCs," i.e., natural killer (NK) cells ([@B2]). ILC1 mainly express IFNγ and TNF and provide defenses against intracellular bacteria and protozoa. Conversely, NK cells, beside IFNγ production, also display cytolytic activity against virus-infected or tumor cells. Unlike ILC1, NK cells also express the transcription factor Eomesodermin (Eomes) ([@B3]). ILC1 appear to be resident populations in intestine, liver, and uterus, while NK cells are present in tissues and recirculate in the blood ([@B4]--[@B9]). A peculiar subset of NK cells residing in murine liver has been recently described and termed tissue-resident NK (trNK) cells ([@B10]). These cells express T-bet, but not Eomes. Liver trNK cells display striking phenotypical similarities with ILC1 described in mucosal tissues ([@B11], [@B12]), suggesting a partial overlap between these two cell subsets. Indeed, studies regarding ILC lineage specifications suggested that liver trNK cells are more related to ILC1 than to "conventional" splenic NK (cNK) cells ([@B5]). Moreover, Daussy et al. demonstrated that liver NK1.1^+^T-bet^+^Eomes^+^ and NK1.1^+^T-bet^+^Eomes^−^ cells represent two distinct lineages of differentiation, which derive from precursors of medullary and peripheral origin, respectively ([@B6], [@B9]). Of note, peculiar Eomes^+^ NK cells, differing from cNK and ILC1, have been identified in murine salivary glands and uterus ([@B7], [@B13]).

Innate immune cells are important components of decidual microenvironment during pregnancy ([@B14]--[@B16]). Among ILCs, we recently identified ILC3 in human decidua during early pregnancy ([@B17]). However, the best-characterized and more abundant ILC population is that of NK cells that, during the first trimester of pregnancy, represents up to 70% of decidual infiltrating lymphocytes (DILs). Human decidual NK (dNK) cells are characterized by CD56^bright^CD16^−^KIR^+^CD9^+^CD49a^+^ phenotype, are poorly cytolytic, and produce low amounts of IFNγ, as compared to peripheral blood (PB) NK cells ([@B15], [@B18]--[@B20]). On the other hand, dNK cells secrete cytokines and chemokines that promote neo-angiogenesis, tissue remodeling and placentation ([@B16]). Similar to humans, also murine dNK cells are abundant during the early phase of pregnancy and display unique phenotypic and functional features ([@B21]). Since we have previously shown that uterine (u)NK and dNK cells may originate, at least in part, from *in situ* precursors ([@B21]) and in light of recent evidences about ILC complexity and differentiation ([@B6], [@B9], [@B10]), here we re-evaluated the nature of uterine and dNK cells in humans and mice, in order to clarify whether they may be ascribed to ILCs previously identified in other tissues or rather represent unique subsets only present in uterus and decidua.

Materials and Methods {#S2}
=====================

Isolation of Human Cells {#S2-1}
------------------------

Endometrial biopsies were obtained from normally cycling women undergoing surgery for ovarian cyst removal at IRCCS AOU San Martino-IST (Genova, Italy). Decidua (d) samples were obtained at 9--12 weeks of gestation from singleton pregnancies of mothers requesting termination of pregnancy for social reasons at IRCCS AOU San Martino-IST (Genova, Italy). The relevant institutional review boards approved the study and all patients gave their written informed consent according to the Declaration of Helsinki. We isolated cell suspensions from decidual and endometrial tissue with GentleMacs (Miltenyi Biotec, Bergisch Gladbach, Germany) and cells were then filtered as previously described ([@B22]). Decidua and endometrial infiltrating lymphocytes were isolated by Fycoll (Cedarlane, Burlington, ON, Canada) gradient centrifugation. Lymphocytes obtained were subsequently analyzed by flow cytometry, stimulated for cytokine production, or sorted for subsequent stimulation and culture. In order to isolate ILC subsets and CD34^+^ cells, DILs were sorted as (CD45^+^CD3^−^CD14^−^CD34^−^CD56^+^CD127^−^CD117^−^)-NKp44^+^CD103^+^, -NKp44^−^CD103^+^, and -NKp44^−^CD103^−^ cells and CD45^+^CD14^−^CD19^−^CD3^−^CD56^−^CD34^+^ cells at FACSAria (BD Bioscience, San Jose, CA, USA), purity was routinely \>95%. Decidual stromal cells (dSC) were isolated as previously described ([@B23]). PB NK cells were isolated with Human NK cell enrichment cocktail-RosetteSep (StemCell technologies).

ILC Culture, Analysis of Cytokine Production, and Degranulation {#S2-2}
---------------------------------------------------------------

Innate lymphoid cell subsets were cultured in U-bottom 96-well plates (Corning, Tewksbury, MA, USA) in RPMI-1640 medium (Lonza, Basel, Switzerland) supplemented with 10% (vol/vol) FCS (Lonza), 1% (vol/vol) glutamine, and 1% (vol/vol) penicillin, neomycin, and streptomycin antibiotic mixture (Lonza and Cambrex, Charles City, IA, USA). When indicated we added 10 ng/ml IL-15 (Miltenyi) and 5 ng/ml recombinant TGFβ (Peprotech). To perform co-culture experiments, dSC and NK cells were plated at the ratio of 1:5 ± α-TGFβ neutralizing antibody (R&D). CD34^+^ cells were cultured in the presence of RPMI-1640 medium supplemented with 10% (vol/vol) human AB serum (Lonza), 1% (vol/vol) glutamine, and 1% (vol/vol) penicillin, neomycin, and streptomycin antibiotic mixture in the presence of 10 ng/ml Flt3-L, 20 ng/ml SCF, IL-7, IL-15, and IL-21 (Milteny) ±5 ng/ml TGFβ. For the analysis of cytokine production, cells were stimulated as indicated in figures with 25 ng/ml PMA, 1 μg/ml Ionomycin (Sigma-Aldrich), 50 ng/ml IL-23, 50 ng/ml IL-15, 10 ng/ml IL-12 (Miltenyi), and 100 ng/ml IL-18 (MBL). To perform intracellular cytokine analysis, cells were stimulated 18 h in the presence of Brefeldin A (BD Bioscience). After stimulation, cells were stained for surface markers, fixed with Cytofix/Cytoperm, and permeabilized with Perm/Wash (BD Bioscience) according to the manufacturer's instructions. To perform supernatants (spt) cell analysis, ILCs were stimulated for 72 h, the spt were collected, and cytokine concentration was evaluated by ELISA multiplex assay (Merck Millipore) and analyzed with Magpix system (Luminex). TGFβ produced by dSC was measured by ELISA multiplex assay in spt collected after 1 week of culture in serum-supplemented RPMI-1640 medium. To perform degranulation assays coupled with analysis of IFNγ production, 72-h-cytokine-activated DILs were co-cultured with K562 cells at an effector:target (E:T) ratio of 1:1, in the presence of anti-CD107a and Monensin (BD Bioscience). After 4 h, cells were washed and stained for surface and intracellular markers.

Mice, Collection of Decidual and Uterine Tissues, and Cell Isolation {#S2-3}
--------------------------------------------------------------------

C57BL/6 mice were purchased from Charles River (Como, Italy). Eomes-GFP reporter mice ([@B6]) were maintained and mated at the Animal Facility of the IRCCS-AOU San Martino-IST. All mice were used between 6 and 12 weeks of age. Housing and treatments of animals were in accordance with the Italian and European Community guidelines (D.L. 2711/92 No.116; 86/609/EEC Directive) and approved by the internal Ethic Committee. To time pregnant females, superovulation was induced by intraperitoneal injection of 5 IU of Pregnant Mares Serum (Folligon; Intervet, Italy) followed, 48 h later, by 5 additional IU of hCG (Corulon; Intervet, Italy). Immediately following injection, each female was mated with a syngeneic male overnight. Females with copulation plug were separated and identified as gestation day (gd) 0.5. Mice were killed at different gd by cervical dislocation and uterus was processed as previously described ([@B21]). Lymphoid cells present in the implant before gd 9 are of maternal origin since fetal hematopoiesis starts at gd 9. Thus, at gd 5.5 uterus was open and the implants were isolated and processed as a source of decidual tissue; while at gd 10.5 and 14.5, the decidua was separated from the implant by cutting away the mesometrial pole and all decidua derived from the same uterus were pooled. Uterine wall, once cleared out of the implants, was further processed. The uteri of virgin females were isolated and processed entirely. Decidual and uterine tissues were mechanically disrupted. Spleen and liver were also collected from virgin and pregnant mice and single-cell suspensions were prepared as previously described ([@B24]).

Flow Cytometry Analyses and Monoclonal Antibodies {#S2-4}
-------------------------------------------------

Human and mouse cells were stained with the monoclonal antibodies listed in Table [1](#T1){ref-type="table"}. Before staining with mAbs, murine cells were incubated with FcR blocking reagent (Miltenyi). For intranuclear staining of transcription factor, cells were stained for surface markers, fixed with Fixation/Permeabilization buffer and permeabilized with permeabilization buffer (eBioscience), respectively, according to the manufacturer's instructions. All samples were analyzed on Gallios Flow Cytometer (Beckman Coulter) or MACSQuant Analyzer (Miltenyi). Data were analyzed with FlowJo software (TreeStar, Ashland, OR, USA). Unstained cells were used as negative controls and markers set accordingly.

###### 

**List of reagents used for flow cytometry analysis**.

  Marker              Fluorocrome          Supplier            Reactivity
  ------------------- -------------------- ------------------- ------------
  β7                  APC                  BD Bioscience       h/m
  CD3                 ECD                  Beckman Coulter     h
  CD3                 PE                   Miltenyi            h
  CD3                 PE/Dazzle594         BioLegend           m
  CD3                 PacificBlue          BioLegend           m
  CD9                 PE                   Miltenyi            h
  CD9                 PE                   eBioscience         m
  CD14                APC-eFluor480        eBioscience         h
  CD14                ECD                  Beckman Coulter     h
  CD34                FITC                 Miltenyi            h
  CD45                APC-H7               BD Bioscience       h
  CD45                biotin               BD Bioscience       m
  CD49a               APC-Vio770           Miltenyi            h
  CD49a               APC                  BioLegend           m
  CD49b               PacificBlue          BioLegend           m
  CD49b               PE                   Miltenyi            m
  CD56                PC7                  Beckman Coulter     h
  CD69                PE                   Miltenyi            h
  CD69                biotin               eBioscience         m
  CD94                FITC                 BioLegend           h
  CD103               PE                   BioLegend           h
  CD103               FITC                 BioLegend           h
  CD107a              FITC                 BD Bioscience       h
  CD117               APC                  Miltenyi            h
  CD117               PerCP-Cy5.5          BioLegend           h
  CD122               PE                   BD Bioscience       m
  CD122               biotin               BD Bioscience       m
  CD127               BrilliantViolet421   BioLegend           h
  CD127               PerCP-Cy5.5          BioLegend           h
  CD158a,h            PE                   Beckman Coulter     h
  CD158b1/b2,j        PE                   Beckman Coulter     h
  CD158e1,e2          PE                   Beckman Coulter     h
  CD160               eFluor660            eBioscience         m
  CD314 (NKG2D)       PE                   Miltenyi            h
  CD335 (NKp46)       APC                  Miltenyi            h
  CD336 (NKp44)       APC                  BioLegend           h
  CD337 (NKp30)       PE                   Miltenyi            h
  NKp46               PE                   eBioscience         m
  NKp46               eFluor660            eBioscience         m
  Eomes               AlexaFluor647        eBioscience         h
  GranzymeA           PE                   BD Bioscience       h
  GranzymeB           PE                   Life Technologies   h
  IFNγ                Alexa647             BD Bioscience       h
  IFNγ                PerCP-Cy5.5          eBioscience         h
  IFNγ                PECy7                BD Bioscience       m
  IL-22               PE                   eBioscience         h
  NK1.1               APC                  BioLegend           m
  NK1.1               PerCP-Cy5.5          eBioscience         m
  Perforin            PE                   Ancell              h
  RORγt               PE                   eBioscience         h/m
  TNFα                eFluor450            eBioscience         h
  TNF                 PE                   Miltenyi            m
  TRAIL               VioBlue              Miltenyi            m
  Live/dead fixable   Aqua Dead            Life Technologies   
  Streptavidin        Alexa-fluor700       Life Technologies   
  Streptavidin        PE                   Life Technologies   
  Streptavidin        eFluor710            eBioscience         

Statistical Analysis {#S2-5}
--------------------

Prism6 GraphPad software was used for statistical analysis. Figures [2](#F2){ref-type="fig"}C,D, [4](#F4){ref-type="fig"}A,C and [5](#F5){ref-type="fig"}B show one-way ANOVA. Figures [4](#F4){ref-type="fig"}E-- G and [5](#F5){ref-type="fig"}H show two-way ANOVA. Figure [5](#F5){ref-type="fig"}F show one-way ANOVA plus post test for linear trend. We considered significant *p*-values ≤0.05.

Results {#S3}
=======

Distinct Eomes^+^ NK Subsets Are Present in Human Endometrium and Decidua {#S3-1}
-------------------------------------------------------------------------

It has been shown that in tonsil and gastrointestinal epithelium NKp44 molecule is expressed by CD56^+^CD127^+^RORγt^+^ ILC3 and CD56^+^CD127^−^CD103^+^ ILCs ([@B8]). Lymphoid cells isolated from human endometrium and decidua contained similar percentages of Lin^−^CD56^+^CD127^+^CD117^+^ RORγt^+^ ILC3 (Figures [1](#F1){ref-type="fig"}A--C) that homogeneously expressed NKp44 (not shown) ([@B7], [@B17]). Among Lin^−^CD56^+^CD127^−^CD117^−^RORγt^−^ cells, we identified three subsets according to NKp44 and CD103 surface expression (Figures [1](#F1){ref-type="fig"}A,D). In particular, NKp44^+^CD103^+^ subset represented a minor fraction of CD56^+^ cells as compared to NKp44^−^CD103^+^ and NKp44^−^CD103^−^ cells (Figures [1](#F1){ref-type="fig"}A,D). The frequency of these three cell subsets did not significantly differ between endometrium and decidua. Thus, the presence of these ILC subsets seems not to depend on pregnancy status. NKp44^+^CD103^+^, NKp44^−^CD103^+^, and NKp44^−^CD103^−^ cells expressed T-bet and Eomes (Figure [1](#F1){ref-type="fig"}E and not shown), thus strongly suggesting that they belong to the NK cell lineage. The analysis of markers commonly used to identify endometrial and dNK cells ([@B15]) revealed that all three subsets were CD49a^+^, while CD9 and CD69 were expressed at higher levels by NKp44^+^CD103^+^ and NKp44^−^CD103^+^ cells than by NKp44^−^CD103^−^ cells. In addition, CD103^+^ subsets expressed integrin β~7~ that, together with CD103, can forms the α~E~β~7~ heterodimer. Moreover, the main activating NK cell receptors, including NKp46, NKp30, NKG2D, and DNAM-1 were homogenously expressed by all three cell populations (Figure [1](#F1){ref-type="fig"}F). All subsets were CD16^−^ CD57^−^and CD94/NKG2A^+^ (Figure [1](#F1){ref-type="fig"}F), while expressing variable amounts of KIRs (Figure [1](#F1){ref-type="fig"}E).

![***Ex vivo* characterization of human endometrial and decidual ILC subsets**. **(A)** Identification of different ILC subsets by surface marker analysis, after gating on Lin^−^CD56^+^ cells. **(B)** Intranuclear expression of RORγt (*n* = 4--8). **(C)** Mean ± SEM of Lin^−^CD127^+^CD117^+^ ILC3 (*n* = 7). **(D)** Percentage of different NK cell subsets after gating on endometrial and decidual Lin^−^CD56^+^CD127^−^CD117^−^ cells (mean ± SEM; *n* = 6 and 28, respectively). **(E,F)** Phenotypic analysis of endometrial **(E)** and decidual **(E,F)** NKp44^+^CD103^+^, NKp44^−^CD103^+^, and NKp44^−^CD103^−^ cells. Control (ctr) corresponds to unstained cells. One representative experiment out of 8 performed.](fimmu-06-00646-g001){#F1}

Decidual Stromal Cells-Derived TGFβ Influences dNK Cell Phenotype {#S3-2}
-----------------------------------------------------------------

The typical features of dNK cells depend, at least in part, from the influence of decidual microenvironment. Previous reports indicated CD103 and CD9 as markers of exposure to TGFβ ([@B8], [@B25], [@B26]). Endometrial and dSC were shown to produce molecules of the TGFβ family ([@B27]). Accordingly, we found that dSC isolated from different donors produced TGFβ (Figure [2](#F2){ref-type="fig"}A). dSC-derived spt or recombinant (r) TGFβ induced *de novo* expression of CD103 and CD9 on PB NK cells. In addition, in the presence of anti-TGFβ (α-TGFβ) neutralizing antibody, the expression of both markers was inhibited (Figure [2](#F2){ref-type="fig"}B). Next, we evaluated the effect of rTGFβ on the three dNK subsets identified. Only the NKp44^+^CD103^+^ subset underwent *in vitro* cell proliferation upon 7 days culture (Figure [2](#F2){ref-type="fig"}C). This result was in accordance with higher *ex vivo* expression of Ki67 (Figure [2](#F2){ref-type="fig"}D). Although TGFβ did not influence cell proliferation (Figure [2](#F2){ref-type="fig"}C), it did affect the phenotypic features of the three subsets. In particular, NKp44^+^CD103^+^ retained CD103 expression only when cultured in the presence of rTGFβ (Figure [2](#F2){ref-type="fig"}E). In agreement with previous studies, NKp44^−^CD103^−^ cells cultured with rTGFβ acquired CD103 ([@B8], [@B26]). CD9 expression was partially downregulated when cells were cultured in the absence of TGFβ (Figure [2](#F2){ref-type="fig"}E). In addition, rTGFβ reduced the expression of NKp30, particularly in NKp44^−^CD103^+^ cells (Figure [2](#F2){ref-type="fig"}E) ([@B28]).

![**TGFβ modulates human dNK cell phenotype**. **(A)** TGFβ concentration (picogram/milliliter) in dSC spt derived from 8 different donors. **(B)** PB NK cells were cultured as indicated for 15 days and analyzed by flow cytometry for the expression of CD103 and CD9; mean ± SEM of positive cells (*n* = 5). **(C)** NKp44^+^CD103^+^, NKp44^−^CD103^+^, and NKp44^−^CD103^−^ dNK cell subsets were sorted and cultured with IL-15 ± rTGFβ. Cell number fold change is depicted, calculated as ratio of cell number at day 20 to that at day 0. **(D)** Ki67 expression on DILs after gating on dNK cell subsets (*n* = 6). **(E)** Sorted dNK cell subsets were cultured for 20 days in IL-15 ± TGFβ and analyzed for the expression of the indicated markers, one representative experiment out of 3 performed. Control (ctr) corresponds to unstained cells.](fimmu-06-00646-g002){#F2}

We also investigated whether rTGFβ could influence dNK cell differentiation from dCD34^+^ hematopoietic precursors. In the presence of rTGFβ, dCD34^+^ cell number fold expansion was affected in two out of three experiments (Figure [3](#F3){ref-type="fig"}A). Differentiation toward Lin-CD56^+^CD161^±^ cells was inhibited (Figure [3](#F3){ref-type="fig"}B). However, CD56^+^ cells expressed higher levels of CD103 and CD9 than cells cultured in the absence of rTGFβ (Figures [3](#F3){ref-type="fig"}C,D). Thus, it is conceivable that uterine/decidual microenvironment, enriched in TGFβ, may play a relevant role in the induction of unique features in recruited or *in situ* differentiated NK cells and in the maintenance of dNK cell phenotype.

![**TGFβ modulates human dCD34^+^ cell differentiation toward CD56^+^CD103^+^CD9^+^ cells**. Purified dCD34^+^ cells were cultured 14 days in the presence of Flt3-L, SCF, IL-7, IL-15, and IL-21 ± rTGFβ **(A)** Cell number fold change calculated as ratio of cell number at day 14 to that at day 0. **(B)** Flow cytometry analysis of *in vitro* differentiated cells after gating on Lin^−^ cells. **(C,D)** Flow cytometry analysis of *in vitro* differentiated cells after gating on Lin^−^CD56^+^ cells, **(C)** mean ± SEM of positive cells (*n* = 3), and **(D)** one representative experiment, gray histogram corresponds to unstained cells, black line gated on Lin^−^CD56^+^ cells.](fimmu-06-00646-g003){#F3}

CD103^+^ Cells Represent the Major Source of IFNγ in dNK Cells {#S3-3}
--------------------------------------------------------------

During the early phases of pregnancy, the balance between inflammation and tolerance is critical ([@B29]). A successful pregnancy needs a "regulatory phase" that inhibits immuno-mediated fetal rejection. However, an early "inflammatory phase" favors embryo implantation thanks to the production of cytokines and chemokines that contribute to tissue remodeling and neo-angiogenesis ([@B30]). Analysis of cytokines produced by the three dNK subsets revealed that CD103^+^ cells expressed higher amounts of IFNγ and TNF than CD103^−^ cells upon stimulation (Figure [4](#F4){ref-type="fig"}A). IL-22 was exclusively produced by ILC3 (Figure [4](#F4){ref-type="fig"}A). dNK cells are classically considered as poorly cytotoxic, in spite of their content of cytolytic granules ([@B15]). All dNK subsets expressed similar levels of perforin, granzymes A and B (Figure [4](#F4){ref-type="fig"}B). After 18 h of stimulation with different cytokine combinations, dNK cell subsets were co-cultured with K562 target cells and analyzed for IFNγ production and CD107a expression. Stimulation of dNK subsets with IL-12 or IL-15, or IL-18 did not induce significant IFNγ production (Figures [4](#F4){ref-type="fig"}C,D). Conversely, cells stimulated with IL-12 + IL-15 expressed higher amounts of IFNγ than unstimulated cells. Moreover, cells cultured with IL-12 + IL-15 + IL-18 produced the highest amounts of IFNγ (Figures [4](#F4){ref-type="fig"}C--E), highlighting the known synergy between these cytokines ([@B31]). CD107a expression was enhanced upon cell stimulation with IL-15, either alone or in combination with other cytokines (Figures [4](#F4){ref-type="fig"}C,D). Remarkably, although NKp44^+^CD103^+^ cells produced the highest amounts of IFNγ and TNF on a per cell basis (Figure [4](#F4){ref-type="fig"}E), this cell subset represented only 2% of CD56^+^CD127^−^CD117^−^ cells (see Figure [1](#F1){ref-type="fig"}D). Indeed, when the amount of cytokines produced was normalized to the relative frequency of the cell subsets, NKp44^−^CD103^+^ cells resulted as the most important source of IFNγ (Figure [4](#F4){ref-type="fig"}F). In any case, all three dNK subsets displayed both lower IFNγ production and CD107a expression than PB NK cells (Figure [4](#F4){ref-type="fig"}G), in line with previous reports ([@B23], [@B26], [@B32]). Thus, decidual microenvironment is likely to affect both the phenotypical and the functional features typical of NK cells.

![**Human decidual NKp44^+^CD103^+^, NKp44^−^CD103^+^, and NKp44^−^CD103^−^ cells produce IFNγ upon cytokine stimulation**. **(A)** DILs were stimulated with P + I + IL-23 for 18 h and analyzed for intracellular cytokine expression after gating on the three dNK cell subsets and ILC3. Mean ± SEM of cytokine positive cells (*n* = 11). **(B)** DILs were analyzed for the intracellular expression of perforin and granzymes. Mean ± SEM of positive cells (*n* = 6). **(C,D)** DILs were stimulated with IL-12, IL-15, and IL-18 alone or in combination. After 72 h, cells were incubated 4 h with K562 cells and analyzed for the expression of IFNγ and CD107a. **(C)** Mean ± SEM of positive cells (*n* = 6) and **(D)** one representative experiment. **(E,F)** dNK cell subsets were sorted and stimulated as indicated. Cell spt were collected after 72 h and analyzed by ELISA multiplex assay for IFNγ and TNF. For statistical analysis, within each stimulation condition, data referred to different cell populations were compared with Tukey's multiple comparison. **(E)** Mean ± SEM of cytokine concentration (picogram/milliliter) produced by 10^4^ cells (*n* = 5). **(F)** Mean ± SEM of cytokine concentration (picogram/milliliter) is normalized to the mean frequency (see Figure [1](#F1){ref-type="fig"}D) of each subset (*n* = 5). **(G)** DILs and PB NK cells were stimulated as indicated. After 72 h, cells were incubated 4 h with K562 cells and analyzed for the expression of IFNγ and CD107a; mean ± SEM of positive cells (*n* = 6).](fimmu-06-00646-g004){#F4}

Murine Uterus and Decidua Contain Eomes^+^CD49a^+^CD49b^+^ and Eomes^+^CD49a^+^CD49b^−^ NK Cell Subsets {#S3-4}
-------------------------------------------------------------------------------------------------------

Previous studies in mice indicated that during midgestation the majority of uterine CD3^−^NK1.1^+^ cells express high levels of Eomes ([@B7], [@B33]). Taking advantage of Eomes-GFP mice, we analyzed the expression of Eomes in dNK and uNK cells (identified as CD3^−^NK1.1^+^ cells) starting from the early phase of pregnancy (gd 5.5). The majority of dNK and uNK cells at gd 5.5 were Eomes^+^ and no differences were detected between pregnant and virgin uteri (Figure [5](#F5){ref-type="fig"}A). A small proportion of CD3^−^NK1.1^+^Eomes^−^ ILC1 was present in uterus and decidua at gd 5.5 and increased in percentages during pregnancy (Figure [5](#F5){ref-type="fig"}B). Both Eomes^+^ and Eomes^−^ cells were T-bet positive (not shown). Uterine and decidua NK1.1^+^Eomes^−^ cells expressed markers of tissue retention (CD49a, CD160, CD9, and CD69) and TRAIL, while they were negative for β~7~ integrin (Figures [5](#F5){ref-type="fig"}C,D). Notably, u- and d-Eomes^+^ cells displayed a bimodal expression of CD49a and β7 integrin, while they homogeneously expressed CD160, CD9, CD69, and TRAIL (Figures [5](#F5){ref-type="fig"}C,D).

![**Peculiar subsets of Eomes^+^ decidual and uterine murine NK cells during pregnancy**. **(A)** Analysis of Eomes expression in CD3^−^NK1.1^+^ cells in the indicated organs isolated from Eomes-GFP mice at gd 5.5; one representative experiment (*n* = 25). **(B)** Mean ± SEM of Eomes^−^ cell percentages among CD3^−^NK1.1^+^ cells at different gd (*n* ≥ 3). (\*) Indicate statistical analysis of data from spleen, decidua, and uterus compared with liver at the same gd. (§) Indicate statistical analysis of data from decidua and pregnant uterus at different gd compared with virgin uterus. **(C,D)** CD3^−^NK1.1^+^ Eomes^+^ and Eomes^−^ cells isolated from decidua and uterus of Eomes-GFP mice at gd 5.5 were analyzed by flow cytometry for the indicated markers (black line), gray histograms correspond to unstained cells **(C)**, or splenic NK cells **(D)**; one representative experiment (*n* ≥ 3). **(E,F)** CD3^−^NK1.1^+^Eomes^+^ cells were analyzed for the expression of CD49a and CD49b. **(E)** One representative experiment (*n* = 6) at gd 5.5. **(F)** Mean ± SEM of percentage of the different subsets of CD3^−^NK1.1^+^Eomes^+^ cells at different gd in decidua and uterus (*n* ≥ 3). **(G,H)** Analysis of CD27 and CD11b expression in the CD3^−^NK1.1^+^Eomes^+^ cells subsets in pregnant uterus and decidua. **(G)** One representative experiment; **(H)** mean ± SEM of percentage of positive cells (*n* = 4).](fimmu-06-00646-g005){#F5}

Typically, CD49a identifies liver Eomes^−^ cells, while Eomes^+^ cNK cells are CD49a^−^CD49b^+^. Strikingly, the simultaneous analysis of Eomes, CD49a, and CD49b allowed the identification of three subsets of NK cells in uterus and decidua: Eomes^+^CD49a^+^CD49b^−^ (population, pop. 1), Eomes^+^CD49a^+^CD49b^+^ (pop. 2), and Eomes^+^CD49a^−^CD49b^+^ cells (pop. 3) (Figures [5](#F5){ref-type="fig"}E,F). The latter population (pop. 3) corresponds to cNK cells, while the other two subsets are only present in uterus and decidua. Notably, in decidua the percentages of Eomes^+^CD49a^+^CD49b^−^ (pop. 1) cells decreased during pregnancy, while cNK cells progressively increased (Figure [5](#F5){ref-type="fig"}F). Of note, Eomes^+^CD49a^−^CD49b^+^ (pop.3) cells are enriched in mature CD11b^high^CD27^low^ cells ([@B24]), while Eomes^+^CD49a^+^CD49b^−^ (pop. 1) and Eomes^+^CD49a^+^CD49b^+^ (pop. 2) contain higher percentages of cells displaying an immature phenotype (CD11b^low/high^CD27^high^), both in decidua and uterus (Figures [5](#F5){ref-type="fig"}G,H). In line with previous results ([@B6]), Eomes^+^ cells produced higher IFNγ and lower TNF than Eomes^−^ cells (Figures [6](#F6){ref-type="fig"}A,B). In decidua and uterus, Eomes^+^CD49a^+^CD49b^−^ (pop. 1) cells mainly produced TNF, while the two subsets of CD49b^+^ (pop. 2 and 3) cells expressed both TNF and IFNγ Figure [6](#F6){ref-type="fig"}C). Therefore, murine decidua and uterus contain different subsets of group 1 ILCs, including ILC1 (Eomes^−^CD49a^+^CD49b^−^IFNγ^low^TNF^high^), cNK (Eomes^+^CD49a^−^CD49b^+^IFNγ^high^TNF^low^), and two novel subsets of NK cells (Eomes^+^CD49a^+^CD49b^−^IFNγ^+^TNF^+^ and Eomes^+^CD49a^+^CD49b^+^IFNγ^+^TNF^+^) characterized by phenotypic and functional features shared by cNK cells and the formerly described trNK cells.

![**Cytokines production by murine Eomes^+^ and Eomes^−^ cells**. **(A--C)** Decidua and uterus (CD3^−^NK1.1^+^) Eomes^+^ and Eomes^−^ cells were sorted from Eomes-GFP mice, stimulated with P + I for 18 h and analyzed for intracellular cytokine expression. **(A)** One representative experiment; **(B)** mean ± SEM of cytokine positive cells (*n* = 3); **(C)** percentages of IFNγ^+^ and TNF^+^ cells in the different Eomes^+^ cell subsets (see Figure [5](#F5){ref-type="fig"}F). Data derived from a pool of 10 mice.](fimmu-06-00646-g006){#F6}

Discussion {#S4}
==========

In the present study, we show that both human and murine uterine microenvironments are enriched in Eomes^+^ ILCs, i.e., NK cells. In particular, human endometrium and decidua NK cells include two subsets of CD103^+^ cells that could be further dissected on the basis of NKp44 expression. We found that decidual CD103^+^ NK cells produce higher amounts of IFNγ than CD103^−^ cells and express markers of tissue residency, that were maintained in culture with TGFβ. In murine uterus and decidua, Eomes^+^ cells are heterogeneous and, besides cNK cells, contain two peculiar subsets dissected by the expression of CD49a and CD49b. In particular, Eomes^+^CD49a^+^CD49b^--^ cells are mainly present during the early phase of pregnancy (gd 5.5) and characterized by TNF production.

Human NK cells represent the most abundant lymphoid population in decidual tissue during the first trimester of pregnancy. This, together with their peculiar phenotypic and functional features, raised many questions regarding their origin. Here, we show that dNK cells express markers suggestive of TGFβ imprinting, such as CD103 and CD9. Eomes^+^CD103^+^CD9^+^ NK cells are already detectable in the endometrium, thus, suggesting that the presence/recruitment of these ILC subsets does not depend on the pregnancy status. Stromal cells present in endometrium and decidua release TGFβ able to induce or maintain expression of these markers on NK cells and on dCD34-derived NK cells. These data suggest that both PB NK cells and dCD34^+^ precursors may be influenced by decidual microenvironment. Whether a similar TGFβ-dependent mechanism occurs also in mice remains to be determined. A population of CD103^+^ cells was described also in the human intestinal epithelia ([@B8]). Intestinal CD103^+^ cells homogeneously express NKp44 and are IFNγ producers. Conversely, most endometrial and decidual CD103^+^ cells do not co-express NKp44 and produce low levels of IFNγ as compared to PB NK cells. Nevertheless, among dNK cells, CD103^+^ cells represent the major source of IFNγ.

A recent report identified in mice Eomes^+^CD49a^+^ cells in the virgin uterus ([@B7]). Here, we show that these cells are also present in pregnant uterus and decidua and that CD49b expression allows the further identification of two subsets of Eomes^+^CD49a^+^ cells only detectable in these tissues. Eomes^+^CD49a^−^CD49b^+^ cNK cells, which are enriched in IFNγ producing cells, are the predominant Eomes^+^ subset during midgestation (gd 10.5) when they might contribute to spiral artery modification ([@B34]). On the other hand, Eomes^+^CD49a^+^CD49b^−^ cells mainly produce TNF, are abundant at gd 5.5 and subsequently decrease. A minor Eomes^−^CD49a^+^ cell population able to produce TNF is also present in decidua and uterus and increases during pregnancy. Thus, a source of TNF is constantly present during early and midgestation.

Studies aiming to characterize ILC subsets in several organs highlighted the complexity of this cell family and suggested that ILCs may display tissue-specific features and developmental requirements. In liver, it has been shown that T-bet^+^Eomes^+^ cNK and T-bet^+^Eomes^−^ ILC1 differentiate from precursors of medullary and peripheral origin, respectively ([@B6]). Our present data indicate that the majority of uNK and dNK cells express Eomes. They might derive from accumulation of circulating Eomes^+^ NK cells. However, in a previous study, we showed that only a minor fraction of dNK cells derives from the migration of splenic NK cells ([@B21]). Conversely, we showed that Lin^−^CD122^+^ NK precursors are present in murine decidua and uterus and give rise to immature NK cells that undergo differentiation during pregnancy ([@B21]). Thus, it is likely that Eomes^+^ NK cells may derive from *in situ* differentiation of precursors of medullary origin. In accordance with this hypothesis, hematopoietic precursors and immature NK cells capable of differentiating toward dNK cells are present also in human decidua and endometrium, supporting an *in situ* development of dNK cells ([@B35], [@B36]).

It is of note that also salivary gland NK cells, although expressing Eomes, display phenotypic features of trNK cells described in liver ([@B13]). Salivary gland Eomes^+^ NK cells are independent of *Nfil3* for their development, while uterine Eomes^+^ NK cells are reduced in *Nfil3*^−/−^ mice ([@B13]). Moreover, Colucci and co-workers (under review) show that *Nfil3* is required for the expansion of Eomes^+^CD49a^+^ NK cells during pregnancy. This, together with our present findings, suggests that peripheral tissues different from liver can sustain the differentiation of peculiar Eomes^+^ NK cells. The developmental relationship among the three subsets of Eomes^+^ NK cells identified here is unknown. NK cell maturation is a four-stage developmental program that starts at a CD11b^low^CD27^low^ stage and leads them through the following stages: CD11b^low^CD27^high^ → CD11b^high^CD27^high^ → CD11b^high^CD27^low^ ([@B24]). Moreover, CD49b is acquired during NK cell differentiation ([@B37]). Here, we show that, among Eomes^+^ cells, CD49a^+^CD49b^−^ cells decrease in percentages during pregnancy, while CD49a^−^CD49b^+^ cells increase. Moreover, CD49a^−^CD49b^+^ cells are enriched in mature CD11b^high^CD27^low^ cells, while CD49a^+^CD49b^−^ and CD49a^+^CD49b^+^ cells contain higher percentages of immature CD11b^low^CD27^high^ cells, both in uterus and decidua. It may be possible to speculate that the three subsets of Eomes^+^ NK cells represent developmentally related differentiation stages, although fate-mapping experiments will be needed to test this hypothesis.

Thus, our data indicate that the formerly indicated uNK and dNK actually represent heterogeneous group 1 ILC populations, including Eomes^−^ ILC1, Eomes^+^ cNK cells, and two novel subsets of Eomes^+^ NK cells, phenotypically and functionally distinct from trNK previously described in other tissues. It is conceivable that they may diverge from the Eomes^+^-developmental pathway under the influence of decidual microenvironment that may contribute to their differentiation. Further studies will be required for better understanding the role of the different ILC subsets in the establishment and maintenance of pregnancy.
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